Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...
Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...
Lung cancer was the fifth largest leading cause of cancer deaths worldwide for those who have never smoked Vanessa Etienne is an Emerging Content Writer-Reporter for PEOPLE. Getty The proportion ...
The proportion of people who have never smoked being diagnosed with lung cancer is rising, with new research pointing to air pollution as a growing contributor to lung cancer around the world.
Mol Cancer Ther (2025) 24 (2): 163–175. Trophoblast cell surface antigen 2 (TROP2) is highly expressed in multiple cancers relative to normal ... cells in both in vitro and in vivo studies. In lung ...
You might have more tests if the scan shows something abnormal. You might be referred to a specialist if it shows that you may have lung cancer. There is evidence that screening people based on their ...
Background Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative ...
Background Patients with interstitial lung disease (ILD) are at risk of developing nocturnal hypoxaemia due to ventilatory restriction and impaired gas exchange that worsen with supine posture and ...
The scan found signs of cancer ... had multiple follow-up appointments. She's stayed in close contact with Cerfolio and his team and is seeing a local pulmonologist to make sure her lung function ...
One of the most serious lung complications related to RA is interstitial lung disease (ILD). This condition can significantly impact a person’s quality of life and overall health." "Interstitial lung ...
Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths. However, the timeline of how the disease progresses can vary based on several factors.
Targeting oncogenes and their interactive partners is an effective approach to developing novel targeted therapies for cancer and other chronic diseases. The MYC family of proteins, which are ...